OxPL-apoB and OxPL-apo(a) tests validated for potential use in Lp(a) studies
January 19, 2026
Chemiluminescent ELISA methods for analysing the oxidised phospholipids, OxPL-apoB and OxPL-apo(a), have been validated for use in clinical, translational, and pharmacological research settings – supporting their potential as biomarker tests for oxidative lipid burden in studies of Lp(a) lowering agents.